SCD and steatosis: Jiang et al have demonstrated that the pharmacological inhibition of SCD1 expression has resulted in increased fatty acid oxidation and reduced de novo fatty acid synthesis and thus steatosis was reduced both in hepatocyte cell line and mouse models [56].